Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(578/week)
Manufacturing
(425/week)
Energy
(320/week)
Technology
(447/week)
Other Manufacturing
(341/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Cyclopentanes
Jun 12, 2020
Sierra Oncology Reports Favorable Long-Term Safety and Dose Intensity Data for Momelotinib
May 28, 2020
Cincinnati Children's HLH Research Points to Treatment for COVID-19 Cytokine Storms
May 27, 2020
Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease
May 14, 2020
Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms
May 11, 2020
AllianceRx Walgreens Prime studies the use of cyclin-dependent kinase 4/6 inhibitors in breast cancer patients
Jan 27, 2020
Global Sialorrhea Market Report 2017-2028: Current Treatment Practices, Emerging Drugs, Market Share of Individual Therapies, Current & Forecasted Market Size
Dec 20, 2019
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018
Dec 09, 2019
Samus Therapeutics Announces Presentation of Phase 1b Study Evaluating Orally Administered PU-H71 with Ruxolitinib in Myelofibrosis at the ASH 2019 Annual Meeting
Dec 07, 2019
Sierra Oncology Reports Decreased Transfusion Requirements for Patients Treated with Momelotinib Directly Compared to Ruxolitinib at ASH Annual Meeting
Dec 02, 2019
Sierra Oncology Announces Investor Event to Discuss Momelotinib Data Being Reported at ASH
Oct 23, 2019
Women living with metastatic breast cancer in British Columbia now have public access to KISQALI®
Sep 29, 2019
Elevar Announces Results from the ANGEL trial, a study of Monotherapy Rivoceranib (Apatinib) in Late-Stage Gastric Cancer Patients
Sep 29, 2019
Novartis Kisqali® delivers consistently superior overall survival - MONALEESA-3 trial demonstrates more life for postmenopausal HR+/HER2- advanced breast cancer patients
Sep 19, 2019
Addition of KISQALI® to drug plan in Quebec expands access to treatment for metastatic breast cancer
Sep 10, 2019
HR Positive/ HER2 Negative Breast Cancer Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Nov 05, 2018
Ascletis to Present Phase II / III Clinical Study for Its All-oral HCV Treatment at the 69th Annual meeting of AASLD
Nov 02, 2018
China Entecavir Investigation Market Report, 2018-2022 - Market Size, Competitive Landscape, Price by Manufacturer & Market Outlook
Sep 26, 2018
China's Gliclazide Market 2018-2022: Sales Value of Gliclazide Kept Rising After the Drug Entered China, and Exceeded CNY 200 Million in 2017
Jun 21, 2018
CASI Pharmaceuticals Enters Strategic Partnering And Contract Manufacturing Agreement With Yiling Wanzhou International Pharmaceuticals For Entecavir And Cilostazol
Jun 03, 2018
Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
Page 1
››
Latest News
Apr 29, 2024
Nordson Electronics Solutions Receives EM China Innovation Award for the New ASYMTEK Select Coat® SL-1040...
Apr 29, 2024
Australian Council to Modernize Water Distribution System with Itron Solutions
Apr 29, 2024
Gilbane Building Company successfully completes construction of the University of Virginia's cutting-...
Apr 29, 2024
Del-Air Expands Service Geography with East Coast Air & Heat Partnership
Apr 28, 2024
AngleLock to Introduce World's First 7th Axis Linear Shaft Motor Gantry for Industry 4.0 at Automate...
Apr 28, 2024
Conditioned Air Association of Georgia Announces "Top 20 under 40" List Recognizing HVAC Industry...
Apr 28, 2024
French FM calls for greater cooperation on European defence
Apr 28, 2024
Dubai begins construction of 'world's largest' airport terminal
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events